MyAverix Finance
LSE · Healthcare
Haleon PLC (HLN)
Drug Manufacturers - Specialty & Generic
Haleon PLC (HLN) is listed on LSE in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-24, reported market cap is $30.46B, P/E ratio is 19.10, net margin is 15.1%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for HLN
Haleon PLC (HLN) — FAQ
What is Haleon PLC's market cap?
Haleon PLC (HLN) has a reported market cap of $30.46B (data as of 2026-05-24).
What is HLN's P/E ratio?
The price-to-earnings (P/E) ratio for Haleon PLC (HLN) is 19.10 (data as of 2026-05-24).
Does Haleon PLC pay a dividend?
Dividend yield is not available in the current snapshot for Haleon PLC (HLN). Check the MyAverix Finance app for the latest dividend data.
What sector is Haleon PLC in?
Haleon PLC (HLN) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is HLN listed on?
HLN is listed on LSE.
What is Haleon PLC's net margin?
Haleon PLC (HLN) reports a net margin of 15.1% (data as of 2026-05-24).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.